Offer - Urjas Oil for just ₹ 1 X
Rosave F is a prescription drug, available for use as Tablet. Secondary and off-label uses of Rosave F have also been mentioned below.
The right dosage of Rosave F depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Rosave F also has some side effects, the most common being Nausea or vomiting, Headache, Constipation. Apart from the aforementioned side effects, Rosave F can also lead to other problems, which have been listed below. Usually, these side effects of Rosave F go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Rosave F is Moderate for pregnant women and Moderate for women who are breastfeeding. Warnings related to Rosave F's effects on the liver, heart and kidney, if any, have been listed below.
Rosave F can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rosave F in conditions like Diabetes.
Drug interactions for Rosave F have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Rosave F is considered not safe while driving, and is not addictive.
Rosave F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rosave F safe for pregnant women?
Pregnant women may experience moderate side effects from Rosave F. It is best to stop taking Rosave F immediately and inform your doctor if you notice any discomfort.
Is the use of Rosave F safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Rosave F. Immediately discontinue Rosave F if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Rosave F on the Kidneys?
Rosave F rarely affects the kidneys.
What is the effect of Rosave F on the Liver?
Rosave F is rarely harmful for the liver.
What is the effect of Rosave F on the Heart?
You may experience side effects on your heart after taking Rosave F. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Rosave F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rosave F unless your doctor advises you to do so -
Is this Rosave F habit forming or addictive?
No, there is no any evidence that Rosave F is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Rosave F can make you feel drowsy.
Is it safe?
Rosave F is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Rosave F is not used to treat mental disorders.
Interaction between Food and Rosave F
Due to a lack of research, nothing can be said about the consequences of taking Rosave F together with food.
Interaction between Alcohol and Rosave F
Information about the interaction of Rosave F and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650